Author:
Mishra Kundan,Sahu Kamal Kant
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference9 articles.
1. Neunert C, Terrell DR, Arnold DM et al (2019) American Society of Hematology 2019 guidelines for immune thrombocytopenia [published correction appears in Blood Adv. 2020 Jan 28;4(2):252]. Blood Adv 3(23):3829–3866
2. Ong SY, Tan CW, Ramya V, Malik AA, Lee XH, Hwang JCC, Yang Y, Ng HJ, Lee LH (2021) Risk factors and predictors of treatment responses and complications in immune thrombocytopenia. Ann Hematol. https://doi.org/10.1007/s00277-021-04424-z
3. Mishra K, Malhotra P, Jandial A, Kumar LD, Varma N, Dhiman RK, Yanamandra U et al (2017) Bleeding risk assessment by sonoclot in severe immune thrombocytopenia. Blood 130(Suppl 1):2320
4. Mishra K, Jandial A, Sandal R, Porchezhian P, Charan S, Lad D et al Poor platelet function on sonoclot signature is associated with high incidence of bleeding in severe immune thrombocytopenia. Blood 132(Suppl 1):4491. https://doi.org/10.1182/blood-2018-99-117086
5. Mishra K, Kumar S, Jandial A, Sahu KK, Sandal R, Ahuja A et al (2020 (accepted) Real-world experience of rituximab in immune thrombocytopenia. Indian J Hematol Blood Transfus 10.1007/s12288-020-01351-3
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献